Cucurbitacin D Overcomes Gefitinib Resistance by Blocking EGF Binding to EGFR and Inducing Cell Death in NSCLCs

In this study, the mechanism of the anticancer effect through which cucurbitacin D (CuD) can overcome gefitinib resistance in NSCLC was investigated. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide assay, and cell migration and growth were observed by woun...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Hong, Se Hyang, Ku, Jin Mo, Lim, Ye Seul, Lee, Seo Yeon, Kim, Ji Hye, Cheon, Chunhoo, Ko, Seong-Gyu
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7041627/
https://ncbi.nlm.nih.gov/pubmed/32133284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00062
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires